Your browser doesn't support javascript.
loading
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
Schmidt, Andrew L; Tucker, Matthew D; Bakouny, Ziad; Labaki, Chris; Hsu, Chih-Yuan; Shyr, Yu; Armstrong, Andrew J; Beer, Tomasz M; Bijjula, Ragneel R; Bilen, Mehmet A; Connell, Cindy F; Dawsey, Scott Joseph; Faller, Bryan; Gao, Xin; Gartrell, Benjamin A; Gill, David; Gulati, Shuchi; Halabi, Susan; Hwang, Clara; Joshi, Monika; Khaki, Ali Raza; Menon, Harry; Morris, Michael J; Puc, Matthew; Russell, Karen B; Shah, Neil J; Sharifi, Nima; Shaya, Justin; Schweizer, Michael T; Steinharter, John; Wulff-Burchfield, Elizabeth M; Xu, Wenxin; Zhu, Jay; Mishra, Sanjay; Grivas, Petros; Rini, Brian I; Warner, Jeremy Lyle; Zhang, Tian; Choueiri, Toni K; Gupta, Shilpa; McKay, Rana R.
Afiliação
  • Schmidt AL; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tucker MD; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bakouny Z; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Labaki C; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hsu CY; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Shyr Y; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina.
  • Beer TM; Oregon Health and Science University Knight Cancer Institute, Portland.
  • Bijjula RR; UPMC Western Maryland, Cumberland.
  • Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Connell CF; Penn State Cancer Institute, Hershey, Pennsylvania.
  • Dawsey SJ; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Faller B; Missouri Baptist Medical Center, St Louis.
  • Gao X; Massachusetts General Hospital, Boston.
  • Gartrell BA; Montefiore Einstein College of Medicine, Bronx, New York.
  • Gill D; Intermountain Healthcare, Salt Lake City, Utah.
  • Gulati S; University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Halabi S; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina.
  • Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan.
  • Joshi M; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Khaki AR; University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle.
  • Menon H; Stanford University, Stanford, California.
  • Morris MJ; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Puc M; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Russell KB; Virtua Health Network, Marlton, New Jersey.
  • Shah NJ; Tallahassee Memorial Healthcare, Tallahassee, Florida.
  • Sharifi N; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shaya J; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Schweizer MT; Moores Cancer Center, University of California, San Diego.
  • Steinharter J; University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle.
  • Wulff-Burchfield EM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Xu W; University of Kansas Medical Center, Westwood.
  • Zhu J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mishra S; Penn State Cancer Institute, Hershey, Pennsylvania.
  • Grivas P; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Rini BI; University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle.
  • Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Zhang T; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Choueiri TK; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina.
  • Gupta S; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • McKay RR; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
JAMA Netw Open ; 4(11): e2134330, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34767021
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / COVID-19 / Antagonistas de Androgênios Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / COVID-19 / Antagonistas de Androgênios Idioma: En Ano de publicação: 2021 Tipo de documento: Article